Nucletron B V

VEENENDAAL, the Netherlands - - Despite Challenging Global Economic Conditions, Nucletron Surpassed Projections for the First Half Year Nucletron, a global leader in radiation oncology, today announced strong financial results over the first half year of 2009.

VEENENDAAL, The Netherlands - Nucletron BV, the innovative cancer radiation solutions company, today announced the creation of an exclusive partnership and plan to merge with sector peer Isodose Control BV for an undisclosed sum.

VEENENDAAL, The Netherlands - Nucletron, a knowledge-based leader in radiation oncology, today announced a new release of Oncentra(R) Brachy, a comprehensive film- and volume-based treatment planning system to optimize cancer treatment planning for brachytherapy.

VEENENDAAL, The Netherlands - Strong Product Offerings and Leadership in Brachytherapy Contribute to All-Time High Nucletron, a global leader in radiation oncology, today announced strong financial results in 2008 with net sales of EUR112.4 million (US $165 million).